Mr. James Van Staveren reports

GLOW ANNOUNCES CLOSING OF DEBT SETTLEMENT

Further to Glow Lifetech Corp.'s press release of Jan. 30, 2024, the company has settled an aggregate of $211,837 of indebtedness owed to an arm's-length creditor through the issuance of 4,236,747 units of the company at a price of five cents per unit. Each unit shall comprise one common share in the capital of the company and one-half a common share purchase warrant. Each warrant shall be exercisable into one common share in the capital of the company at a price of seven cents per warrant share until two years from the date of issuance of the warrants. All common shares issued in connection with the debt settlement are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.

About Glow Lifetech Corp.

Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical- and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has rights to the groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.

We seek Safe Harbor.